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INTRODUCTION 
Recently, National Institutes of Health (NIH) awarded a 5 year $ 6 million grant to 
the University of South Carolina (USC) to establish a Center of Excellence for 
Complementary and Alternative Medicine Research on Autoimmune and Inflammatory 
Disease. The University of California Los Angeles and the Mount Sinai School of 
Medicine were the only other institutions awarded centers in 2007. Previously centers 
have been awarded at Harvard Medical School, Massachusetts General Hospital, Oregon 
State and Temple universities, and the universities of Maryland, North Carolina and 
California-San Francisco. The underlying focus of the NIH Center at USC is to study the 
mechanisms by which plant products suppress inflammation so that they can be used as 
preventive or therapeutic modalities against autoimmune diseases 
(http://camcenter.med.sc.edu/). The goal of this review is to provide an understanding of 
inflammation, discuss its role in health and disease, and provide an overview of how the 
NUT Center award and research in inflammation at the USC School of Medicine (SOM) 
provides the niche to bring together many research focus areas in basic and clinical 
sciences by providing a platform for multidisciplinary collaborations and research 
advancement. 
Inflammation which is defined clinically as heat, pain, redness, and edema, actually 
results from a physiological response to tissue injury and infection (Oke and Tracey, 
2007). Inflammation is a double-edged sword—while it is critical in restoring tissue 
homeostasis following damage secondary to invading pathogens, foreign bodies, and 
trauma, inflammation can also trigger acute and chronic diseases. This list includes major 
pathological disorders such as autoimmune diseases, allergies, cardiovascular diseases, 
neurodegenerative diseases and cancer. Thus, inflammation plays a critical role in the 
pathogenesis of a wide range of diseases. 
Inflammation can be classified as either acute or chronic. During acute 
inflammation, the body responds to harmful stimuli through movement of plasma and the 
white blood cells of the immune system, called leukocytes, from the blood into the 
injured tissues. Acute inflammation plays a critical role in clearing infections and in 
tissue healing. If the inflammation persists for prolonged periods, it is known as chronic 
inflammation. This can lead to a progressive shift in the nature of immune cells that are 
present at the site of inflammation and can trigger tissue destruction, injury and organ 
failure. During inflammation, the cells of the immune system release a large number of 
chemical mediators known as chemokines and cytokines. Some of the important 
cytokine mediators include interleukin (IL)-l, IL-6, tumor necrosis factor (TNF), and 
interferon gamma (IFN). In the early stages of inflammation, the predominant cell type 
infiltrating the tissues is the neutrophil. In contrast, accumulation and activation of 
macrophages is the hall mark of chronic inflammation. In addition, lymphocytes also 
contribute towards the development of inflammation by producing cytokines and 
chemokines. 
Autoimmune diseases are disorders in which the immune system, for reasons that are 
not clear, starts destroying an individuals own cells, tissues or organs by triggering 
inflammation. These diseases include more than 80 serious, chronic illnesses that involve 
almost every human organ system. Collectively, they affect 15-20 million people in the 
USA. They are more common in women and are considered to be among the 10 leading 
causes of death in women in the US under the age of 65 years. Currently, there is no 
known cure for autoimmune diseases. Prominent examples of these diseases include 
Coeliac disease, diabetes mellitus type 1 (IDDM), systemic lupus erythematosus (SLE), 
Sjogren's syndrome, multiple sclerosis (MS), Hashimoto's thyroiditis, Graves' disease, 
idiopathic thrombocytopenic purpura, myesthenia gravis and rheumatoid arthritis (RA). 
The main objective of newly funded NIH Center at USC is to conduct research that 
would determine whether various plant-derived compounds possess immunosuppressive 
activity and to determine their efficacy against autoimmune diseases. Initially, the NIH 
Center will pursue three projects. Project one, led by Dr. Prakash Nagarkatti from the 
USC SOM, will investigate the effect of resveratrol (trans-3,5,4'-trihydroxystilbene) on 
experimental allergic encephalomyelitis (EAE), a model for human MS. Resveratrol, a 
polyphenolic compound found in plant products including red grapes, exhibits anticancer, 
antioxidant, and anti-inflammatory properties. Recently, we demonstrated that resveratrol 
treatment decreased the clinical symptoms and inflammatory responses in an 
experimental MS model (Singh et ah, 2007). Resveratrol was shown to act through the 
Aryl Hydrocarbon receptor (AhR) and estrogen receptors (ER) found on immune cells 
which, in turn, triggered apoptosis (programmed cell death) in these cells. Resveratrol 
administration also led to significant down-regulation of certain cytokines and 
chemokines including TNF-alpha, interferon-gamma, and the interleukins (IL)-2, IL-9, 
IL-12, IL-17, for instance (Singh et ah, 2007). These studies suggest that resveratrol and 
other plant-derived products may be benefiscial in the treatment of not only autoimmune 
diseases but also other inflammatory disorders as well. Project two, led by Dr. Mitzi 
Nagarkatti, will investigate the effect of compounds isolated from hemp oil on the 
suppression of the immune response which may be beneficial in the treatment of 
autoimmune hepatitis. Project three, led by Dr. Lome Hofseth from the USC College of 
Pharmacy will test the efficacy of American ginseng on colitis and colon cancer. 
Preliminary studies suggest that ginseng is very effective in suppressing colitis and 
development of colon cancer in an experimental model. The Center will also provide 
core resource facilities, which will enable, the screening of the potential toxic effects of 
plant-derived compounds on the immune system. These facilities will be led by Drs 
Narendra Singh and Robert Price from the USC SOM. The Center will also create 
training opportunities for new investigators to pursue research on CAM and establish the 
basis upon which to initiate clinical trials on compounds that exhibit efficacy against 
specific autoimmune diseases. 
While the USC School of Medicine has many areas of research strengths, three 
specific research areas have been identified for further development. These areas include 
cancer, cardiovascular diseases and neuroscience. It is interesting to note that 
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inflammation is a common thread that weaves throughout the pathogenesis of diseases 
represented in these areas. 
INFLAMMATION AND CANCER 
Although inflammation is a necessary response to clear infections and to repair tissue 
injury, chronic inflammation has been shown to correlate an increased risk of developing 
cancer. Recent studies have revealed that inflammation is a critical component of tumor 
progression (Coussens and Werb, 2002). Inflammation functions at all three stages of 
tumor development: initiation, progression and metastasis. Inflammation contributes to 
the initiation of cancer by triggering the release of a variety of cytokines and chemokines 
which in turn cause oxidative damage, DNA mutations, and other changes in the 
microenvironment. Such changes make it more conducive for cell transformation and the 
increased survival and proliferation of tumor cells. Such novel insights are leading to the 
use of anti-inflammatory agents as therapeutic approaches to prevent cancer development 
and progression. The recognition of the importance of inflammation to oncogenesis has 
led to clinical trials investigating the use of anti-inflammatory drugs, such as COX-2 
specific inhibitors for cancer prophylaxis and treatment. A NIH think tank on cancer 
biology has recently dealt with this topic at length 
(http://dcb.nci.nih.gov/thinktank/Executive_Summary_of_Inflammation_and_Cancer_Th 
inkTank.cfm). 
CARDIOVASCULAR DISEASES AND INFLAMMATION 
It is becoming increasingly clear that inflammation of blood vessels is one of the 
major factors that increase the incidence of cardiovascular diseases, including 
atherosclerosis, hypertension, stroke and myocardial infarction or heart attack. Initiation 
and progression of vascular inflammation is a complex process involving macrophages of 
the immune system. The proinflammatory mediators produced by macrophages increase 
tissue oxidative stress and lipid retention, which participate directly in vascular 
remodeling (Yan and Hansson, 2007). Normally, endothelial cells (ECs), which line the 
blood vessel, resist adhesion by leukocytes. However, triggers of atherosclerosis, such as 
consuming a high-saturated-fat diet, smoking, hypertension, hyperglycemia, obesity, or 
insulin resistance, can initiate the expression of adhesion molecules by ECs, thus 
allowing the attachment of leukocytes to the arterial wall (Libby, 2006). After adhering 
to the endothelium, blood monocytes penetrate the endothelial lining and mature into 
macrophages, and engulf modified lipoproteins. Cholesterol esters accumulate in the 
cytoplasm, and the macrophages become foam cells through lipid uptake which 
characterizes the early stages of atherosclerosis. Also, the macrophages multiply and 
release several growth factors and cytokines, thereby amplifying and sustaining 
proinflammatory mediators (Libby, 2006). Thus, inflammation is central to the 
progression from fatty streak to complex plaque. Recent studies suggest that drugs 
commonly prescribed to lower cholesterol such as statins also reduce inflammation, 
suggesting an additional beneficial effect of such drugs. 
Similar inflammatory tissue processes are also involved in the pathogenesis of 
hypertension. It is becoming increasingly clear that known mediators that increase blood 
pressure, such as angiotensin-II, also increase oxidative stress and inflammation both of 
which contributes to the target organ damage to the heart, brain, kidney, and blood 
vessels secondary to the hypertensive process. Our laboratory has recently demonstrated 
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that certain endogenous neuropeptides, such as calcitonin gene-related peptide, improve 
hypertension by vasodilation and inhibiting oxidative stress and inflammation (Bowers et 
al., 2005). These studies provide an opportunity for the development of new 
pharmacologic targets to treat hypertension and its deadly consequences. 
INFLAMMATION AND NEURODEGENERATIVE DISEASES: 
There is growing evidence that links immune system and the CNS. For example, 
various immune cells can traverse the blood-brain barrier. During the development of the 
CNS, blood monocytes populate the brain to differentiate into microglia. Invading 
lymphocytes can attack target antigens in the CNS such as during MS or produce growth 
factors that might protect neurons against degeneration. Immune molecules, such as 
interleukins and chemokines, are also expressed at high levels in neurons and may be 
involved in the communication of neurons with glial cells. Moreover, the inflammatory 
reflex is a neurophysiological mechanism that regulates the immune system (Oke and 
Tracey, 2007). The efferent branch of the reflex include the cholinergic anti-
inflammatory pathway involving the vagus nerve, which inhibits inflammation by 
suppressing cytokine synthesis through the release of acetylcholine in immune organs, 
the liver, and the gastrointestinal tract. Thus, such a neurological control mechanism 
regulates inflammation via acetylcholine and suppresses production of proinflammatory 
cytokines (Oke and Tracey, 2007). 
Inflammation during neurodegenerative disorders can be triggered by a number of 
causes including protein aggregates, molecules released from or associated with injured 
neurons or synapses, and dysregulation in the mechanisms that control inflammation. 
The resulting inflammatory responses may modulate neurodegenerative pathways with a 
potential beneficial or detrimental effect. Emerging evidence suggests that inflammation 
may account for chronic neurodegenerative diseases such as Alzheimer's disease (AD), 
Parkinson's disease (PD) and Creutzf el dt-Jakob disease (Minghetti, 2005). In these 
diseases, inflammation is atypical and occurs in the absence of robust leucocyte 
infiltration. In these diseases, resident microglia which are the macrophages of brain 
parenchyma appear to play a major role. In healthy normal brain, microglia are present 
in an inactive phase as compared with other tissue macrophages, but subtle 
microenvironmental changes can induce microglia to react rapidly, change morphology 
and acquire an array of functions, including phagocytosis and secretion of inflammatory 
mediators. In addition to microglia, reactive astrocytes contribute to the process by 
restricting the area of lesion and releasing local mediators. This localized process, is 
distinct from inflammation seen in other tissues and is often referred to as 
'neuroinflammation' (Minghetti, 2005). This unique neuroinflammation is a double-
edged sword which is both neuroprotective as well as can trigger neurodegenerative 
disorders (Minghetti, 2005). Thus, understanding the dynamic relationship between 
beneficial and detrimental effects of neuroinflammation is central to the prevention and 
treatment of neurodegenerative diseases. 
TREATMENT OF INFLAMMATION 
Historically, anti-inflammatory drugs were discovered when certain plants and their 
extracts were found to relieve pain, fever and inflammation (Rainsford, 2007). Salicylates 
were discovered in the mid-19th century from Willow and this enabled the synthesis of 
acetyl-salicylic acid leading to development of Aspirin. Subsequent research in 19th-
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20th centuries led to the development of the non-steroidal anti-inflammatory drugs 
(NSAIDs), most of which were initially organic acids, but later non-acidic compounds 
were developed. The major adverse effects associated with NSAIDS were the associated 
gastro-intestinal (GI) toxicity. In the 1990's two cyclo-oxygenase (COX) enzyme 
systems controlling the production of prostaglandins (PGs) and thromboxane (TxA2) 
were discovered. COX-1 produces PGs and TxA2 which play a role in gastrointestinal, 
renal, and vascular functions, and COX-2 produces PGs which are involved in 
inflammation, pain and fever. This led to the discovery of inhibitors of the COX 
enzymes. While COX-2 inhibitors were enthusiastically received due to their low GI side 
effects, there are recent concerns regarding an increase in cardiovascular toxicity of these 
agents. Because inflammation plays a crucial role in the pathogenesis of a wide range of 
diseases including autoimmune diseases, allergies, cancer, cardiovascular diseases and 
neurodegenerative diseases as discussed above, one can imagine how crucial it is to 
discover new anti-inflammatory drugs, and the potential impact such discoveries will 
have on human health and disease. 
CONCLUDING REMARKS : 
Inflammation is a process that enables the host to fight and overcome infections, 
cancer and help repair damaged tissues. Interestingly, however, inflammation has 
become one of the hottest areas of medical research because it also plays a significant 
role in the pathogenesis of a large number of human diseases, including autoimmune 
diseases, allergies, cardiovascular diseases, neurodegenerative diseases and cancer. It is 
indeed distressing that despite extensive research, highly effective treatment modalities 
do not exist to treat inflammation. The concept that inflammation contributes to the 
underlying cause of such varied diseases is so intriguing because it suggests the 
possibility to treat major human ailments through a single inflammation-reducing agent. 
Thus, it is not surprising that the NIH in its new roadmap initiatives for 2008 has 
identified inflammation as one of the key topics. The NIH website 
(http://nihroadmap.nih.gov/2008initiatives.asp) states, "While significant breakthroughs 
have occurred in our understanding of inflammation, research is needed to further 
understand inflammatory processes. Because inflammation is broadly implicated in many 
diseases and conditions, this initiative would be valuable in uncovering as-yet-unknown 
immune mechanisms and mediators of inflammation as well as genetic factors, 
environmental triggers, and the relationship of inflammation to disease". 
The USC SOM is excited about the recognition of its research efforts afforded by the 
NIH to initiate and develop the Center for Autoimmune and Inflammatory diseases with 
the research focus on inflammation, and we believe that this initiative provides us with 
the niche not only to advance research on inflammation but also extend it to other areas 
of research including cancer, cardiovascular diseases and neurodegenerative disorder. 
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POLYMER NANOCOMPOSITES 
Polymer nanocomposites are composite materials that consist of nanoscale additives 
dispersed in a polymer matrix where, typically, a layered material capable of exfoliation 
into nano-sized platelets is incorporated into the polymer. Since the composites are mixed 
on the nanometer length scale, they often exhibit enhanced properties compared to their 
macroscale counterparts, such as improved strength, stiffness, thermal stability, 
biodegradability, flame resistance, and gas barrier (Schmidt et al. 2002). Types of 
polymer matrices studied include, but are not limited to, vinyl polymers 
(polymethacrylate, polystyrene), condensation polymers (Nylon, polyethylene 
terephthalate), polyolefins (polypropylene, polyethylene), epoxides, rubber, and other 
specialty polymers such as polypyrrole and polyaniline (Ray and Okamoto 2003). 
Additives that are potential candidates for polymer nanocomposites include natural, 
commercial, and synthetic clays, layered silicic acids, layered hydroxides, layered double 
hydroxides, layered alumino-phosphonates and other metal oxides (Utracki et al. 2007). 
However, the vast majority of nanocomposite research is directed towards polymer 
matrices containing layered silicate platelets of nanometer thickness and high aspect ratio 
and these types of nanocomposites will be highlighted in later sections. 
Nanocomposite materials are useful in a wide variety of applications in medical, 
automotive, fiber, textile, coatings, electronics, and packaging industries, among others. 
Research in this area has increased substantially after a Toyota research team developed 
one of the first successful montmorillonite-Nylon-6 nanocomposites in an effort to use 
Nylon-6 based parts in engine compartments and for automotive applications (Kojima et 
al. 1993, Usuki et al. 1993). Since then, layered-oxides, specifically layered silicates, 
have attracted a great interest as additives (Schmidt et al. 2002, Ray and Okamoto 2003, 
Kojima et al. 1993, Usuki et al. 1993, Alexandre et al. 2002, Alexandre and Dubois 
2000, Bharadwaj et al. 2002, Carrado 2003, Chang et al. 2003, Chang and Yeong 2002, 
Dai and Huang 1999, Fornes et al. 2002, Garces et al. 2000, Gilman et al. 2000, 
Gopakumar et al. 2002, Grunlan et al. 2004, Hoffman et al. 2000, Imai et al. 2003, Jan 
and Lee 2004, Jordan et al. 2005, Matayabas et al. 2000, Pinnavaia and Beall 2000, 
Sekelik et al. 1999, Strawhecker and Manias 2000, Kim and Kim 2007, LeBaron et al. 
1999, Tsai 2000). 
Researchers at Eastman Chemical Company expanded on the work of Toyota, by 
incorporating montmorillonite, ion-exchanged with alkylammonium compounds, into 
polyethylene terephthalate (PET) via melt-blending and in-situ polymerization 
(Matayabas et al. 2000a, Matayabas et al. 2000b). They found that at even a low weight 
loading of montmorillonite clay, the oxygen permeability decreased dramatically. This 
was an important finding for Eastman, a leading producer of PET, as their motivation was 
to increase the gas barrier of PET for use in food and beverage packaging. Although 
research in polyester-clay nanocomposites is in a relatively early stage, over 28 patents 
for PET-clay nanocomposites were issued between the years of 1991 and 1998, 
suggesting that this a thriving area of research (Tsai 2000). Earlier methods of 
incorporating montmorillonite clay into PET were usually based on melt-blending, or 
melt-intercalation by extrusion. Typically these method do not facilitate full exfoliation 
of the clay layers but, nonetheless, there were some successful well-exfoliated 
nanocomposites produced where exfoliation and enhancement in properties were 
achieved (Vidotti et al. 2004, Yan et al. 2004). More recently, analogous to the research 
developed by Eastman, layered clays like montmorillonite, talc, and mica were ion-
exchanged with compatibilizers or surfactants and incorporated into PET by in-situ 
polymerization to improve gas barrier (Sekelik et al. 1999, Ke and Yongping 2005, Ke et 
al. 1999, Chang et al. 2004, Tsai et al. 2005). Most recently, layered double hydroxides 
(LDHs) were ion-exchanged with anionic surfactants dodecylsulfate, dodecylbenzene 
sulfate, and octyl sulfate and incorporated into PET by melt-extrusion (Lee et al. 2006). 
Only the dodecyl sulfate LDH was well exfoliated in the PET matrix, and consequently 
the thermal and mechanical properties were enhanced. This research is encouraging as 
only a select few PET nanocomposites are prepared with a layered oxide other than a 
layered silicate. However, gas barrier properties were not studied for this nanocomposite 
system. 
Although PET is the polymer traditionally used for packaging materials, research into 
biodegradable packaging materials is being developed for environmental reasons. 
Montmorillonite was mixed into a biodegradable potato starch by melt blending (Avella 
et al. 2005), where complete intercalation of the starch into the interlayer galleries was 
achieved, as well as and increase in tensile strength and modulus. The nanocomposite 
films formed complied with European regulations for biodegradable materials and 
therefore could be used as alternative packaging materials. Gas barrier was not measured 
for these nanocomposites. 
Epoxy-clay nanocomposites have also been well established for over a decade. 
Typically the clay layers are expanded with onium ions and then the epoxide, curing 
agent, or a mixture of both, are intercalated into the interlayer gallery regions of the clay 
(Messersmith and Giannelis 1994, Wang and Pinnavaia 1998). This has been a proven 
method to exfoliate the clay layers into the epoxy matrix which improves mechanical 
properties, thermal stability, and solvent resistance. 
Similarly, the most successful polystyrene-clay nanocomposites were prepared by 
melt-intercalating the polymer above its melting point into the interlayer galleries that 
had been previously expanded by quaternary alkylammonium ions (Via et al. 1996). 
Another polystyrene (PS) nanocomposite was prepared by covalently modifying layered 
mesostructured aluminosilicates (LMAS) with hexadecyl groups and mixing the organo-
alumniosilicate with polystyrene by microcompounding (Chastek et al. 2005). The PS-
LMAS had increased elastic modulus and strength. Although the LMAS were well 
dispersed, they appeared as stacks according to transmission electron microscopy images. 
Poly(styrene-butadiene), a synthetic rubber copolymer, was intercalated into 
dioctadecyldimethyl ammonium exchanged montmorillonite by mixing the copolymer 
and the organoclay at 120 °C (Laus et al. 1997, Laus et al. 1998). The nanocomposite 
formed showed an increased storage modulus. Natural rubber reinforced with organo-
montmorillonite resulted in a 350% increase in strength without sacrificing the elasticity 
(Arroyo et al. 2003). Other research in rubber nanocomposites has indicated that silane 
modified kaolinite increases the compatibility between the hydrophilic clay and the 
rubber matrix, thus reinforcing the rubber (Dai and Huang 1999). 
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A polypropylene-bentonite nanocomposite is a yet another example of a clay that has 
been organically modified with a quaternary organic salt and that was added to a polymer 
matrix (Dai and Huang 1999). Bentonite, a layered aluminosilicate similar in structure 
to montmorillonite, was mixed with polypropylene using a batch mixer at 150-210 °C at a 
1-5 wt. % loading. The main result obtained was that the nanocomposites containing 
organo-bentonite had a higher thermal stability than nanocomposites formed with natural 
clays. The authors explain this phenomenon by the formation of a nano structure that 
reduced diffusion of oxygen into the material. 
While the above nanocomposite materials mostly utilized layered silicates to 
reinforce the polymer matrix, other layered oxides are being incorporated into polymer 
matrices for use as electrolyte materials and conducting nanocomposites, among others. 
An example of a PET-LDH nanocomposites was briefly presented earlier, but other LDH 
polymer nanocomposite systems are being studied. In contrast to silicates, LDHs have a 
positive charge on brucite-like Mg(OH)2 layers, which can be compensated for by 
anions or polymeric anions (Wilson et al. 1999). This results in an interesting layer 
chemistry of the materials and makes them attractive for applications such as ion-
exchange, catalysis, and even as antacids (Constantino and Pinnavaia 1995, Ookubo etal. 
1993, Playle et al. 1974). Early research in polymer-LDH research was based on 
intercalation of anionic polymers poly(styrenesulfonate) (PSS) and poly (vinyl sulfonate) 
(PVS) into the galleries of a carbonate-containing LDH, confirmed by an increase in the 
interlayer spacing by X-ray diffraction (Wilson et al. 1999). Similarly, another LDH was 
modified by ion-exchange with sodium dodecylsulfate or polyoxyethylene sulfate to form 
biocompatible nanocomposites (Yang et al. 2005). Making use of the anion exchange 
capacity of LDHs, a poly(ethylene oxide) (PEO)-LDH was prepared for potential use as a 
polymer electrolyte (Liao and Ye 2004). An oligo(ethylene oxide) (OEO) modified LDH 
was made by a template method and then subsequently mixed with PEO. The LDH layers 
remained well exfoliated due to the compatibility between the OEO and the PEO. The 
PEO-LDH nanocomposite exhibited a substantial enhancement in conductivity compared 
to the pristine PEO. 
Recently, nanosheets of layered metal oxides have attracted interest as additives for 
nanocomposite electrolytes because of their physicochemical properties and ability to be 
intercalated with various species (Pang et al. 2005). Specifically, polyaniline-vanadium 
oxide nanocomposites are being explored because of their mixed electronic charge-
transport properties (Wu et al. 1996). 
A polyaniline-V205 nanocomposite was formed by in-situ polymerization of aniline 
intercalated into the layered V205 under hydrothermal conditions (Pang et al. 2005). 
Polyaniline- V205 nanocomposite sheets formed with a thickness between 10-20 nm and 
lateral dimensions on the range of hundreds of nanometers to several microns. 
Poly(ethylene oxide) (PEO) was also intercalated into a lithium trivanadate, LiV308, to 
prepare a solid polymer electrolyte with potential applications in lithium batteries.53 PEO 
is widely doped with lithium salts but efforts are underway to improve the conductivity of 
the doped-PEO. LiV308 is a promising material for lithium batteries because the 
structure allows for reversible ion-exchange of lithium cations. When the PEO is mixed 
with the LiV308 under semi-hydrothermal conditions, the PEO partially exfoliates the 
LiV308 layers. The PEO- LiV308 nanocomposite showed a higher ionic conductivity 
than LiV308 and other lithium salt polymer electrolytes (Yang et al. 2005). This research 
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is a step towards the incorporation of other layered lithium containing metal oxides into 
polymers to form conducting nanocomposites. PEO was also introduced into the 
interlayer galleries of HNbW06 1.5 H20 using melt-intercalation for another potential 
solid polymer electrolyte (Sairam and Viswanathan 2002). HNbW06 1.5 H20 has a 
tetragonal structure with layers of NbW06 slabs made up of Nb/W oxygen octahedra, 
separated by interlay er water molecules. It was found that as the intercalation time (i.e. 
heating of a HNbW06 1.5 H20 -PEO pressed pellet to 75 °C) was increased, the 
conductivity also increased. 
Finally, and most recently, layered zirconium phosphates were synthesized and 
exfoliated into platelets with a high aspect ratio (>1000) for incorporation into various 
polymer matrices (Alberti et al. 2007, Sun et al. 2007, Zhang et al. 2007). The zirconium 
phosphates (ZrP) have an advantage over layered clays because of synthetic control over 
the dimensions and surface functionalities (Sun et al. 2007). A layered ZrP, 
Zr(HP04)2 H20 was exfoliated using tetrabutylammonium hydroxide (TBA+OH-), and 
then the exfoliated platelets were isolated after centrifugation. These TBA+ exchanged 
platelets were then re-dispersed into acetone and mixed with an epoxy monomer. The 
acetone was evaporated and a curing agent was added to form an epoxy nanocomposite 
containing well exfoliated ZrP platelets with high aspect ratio (Sun et al. 2007). 
Similarly, ZrP was exfoliated using alkylamines and intercalated with an acrylamide 
monomer, which was subsequently polymerized to form a polyacylamide-ZrP 
nanocomposite (Zhang et al. 2007). This nanocomposite had improved thermal stability, 
most likely from the retardant effect of the exfoliated ZrP layers. A Nafion membrane 
was also prepared with the addition of the same ZrP to enhance the stability of proton 
conductivity at higher temperatures, by increasing the stiffness of the composite 
membrane (Alberti et al. 2007). 
These examples of successful nanocomposites reiterate the fact that research in this 
area is promising and a plethora of nanocomposite materials are being explored for a 
wide variety of applications. However, there are still obstacles present, such as 
incomplete exfoliation of the oxide, incompatibility of the oxide and the polymer, and the 
sacrifice of some properties for the enhancement of others. Ongoing research aims at 
finding ways to overcome these obstacles and to produce quality nanocomposites with 
improved gas barrier property and ideally, enhancements in mechanical properties as 
well. As an in-depth example of one type of polymer nanocomposite, a summary of the 
structure, properties, and preparation of PET based polymer nanocomposites is given 
below. 
1.2. POLYETHYLENE TEREPHTHALATE 
Polyethylene terephthalate (PET) is a polyester that is used in a variety of industrial 
applications, especially in the food and beverage industry as packaging material. 
Therefore it is imperative that the PET packaging retains a barrier to gases such as carbon 
dioxide and oxygen, as well as water vapor. PET has many desirable properties for a 
packaging material including clarity, color, processability, chemical resistance, 
recyclability and, most importantly for food and beverage containers, tastelessness 
(Matayabas and Turner 2000). However, PET alone has minimal gas barrier and, 
therefore, using it as packaging for foods and beverages that are sensitive to oxygen or 
loss of carbon dioxide is problematic. Thus, there has been a recent thrust in 
nanocomposite research to improve the gas barrier of PET, so that the shelf-life of 
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products like beer, wine, and tomato-based products can be extended. Matayabas et al. 
2000, Sekelik et al. 1999, Kim and Kim 2007, Matayabas and Turner 2000). 
PET has been produced commercially for over 50 years, and is manufactured from 
ethylene glycol (EG) and terephthalic acid (TPA) or dimethylterephthalate (DMT) (Kim 
and Kim 2007). The polymerization of PET requires two main steps, transesterification or 
direct esterification, followed by polycondensation. Both esterification processes produce 
BHET, an oligomeric precursor to PET. In the final step excess EG is removed upon 
heating BHET to about 280°C during polycondensation to form PET. This reaction 
scheme is shown in Figure 1.3. 
Once PET is formed, there are two main methods of dispersing the additives to 
prepare nanocomposites: melt-blending or in-situ polymerization (Kim and Kim 2007, 
LeBaron et al. 1999, Tsai 2000, Ray and Okamoto 2003). Melt-blending involves mixing 
the polymer and the additive above the melting point of the polymer under high shear 
force. Melt-blending is typically used industrially to produce large scale quantities of 
PET, so it is advantageous to produce nanocomposites by the same method. 
However, the main difficulty lies in successfully exfoliating the layered additives by 
shear force alone. Few have reported the successful formation of PET nanocomposites by 
this method (Davis et al. 2001, Lyatskaya and Balazs 1998). For in-situ polymerizations, 
a PET monomer is intercalated into the layered structure, and subsequently polymerized. 
The most important advantage of this method is the fact that exfoliation of the layers is 
promoted and maintained by the presence of the intercalated polymer. As discussed 
earlier, exfoliation is a key to producing quality nanocomposites. The main disadvantage 
is that large-scale production of nanocomposites by this method is a difficult and time-
consuming task. 
1.3. LAYERED OXIDES 
As previously mentioned, layered oxides are good candidates for nanocomposite 
additives because their layered structure allows for exfoliation and subsequent 
incorporation into polymer matrices. Simply stated, layered oxides are any oxygen-
containing layered material such as, cuprates, titanates, phosphonates, niobates, or 
silicates. However, layered silicates are the most utilized layered material in the vast 
majority of ongoing research in layered-oxide nanocomposites. Layered silicates, or 
phyllosihcates, represent a large class of clay minerals that are distinguished by layers of 
silicate sheets coordinated to other metal-oxygen sheets. Groups in this class include 
micas, kaolins, vermiculites, chlorites, talc, pyrophyllite, and smectites. Smectites are the 
largest and one of the most widely studied groups because they are common in temperate 
soils, and have a high cation exchange capacity and a large aspect ratio (Carrado et al. 
2001, Carrado 2004, Kloprogge et al. 1999). Two of the most researched smectites of 
this structure type are montmorillonite and hectorite. Montmorillonite is a readily 
available clay, while hectorite is an easily synthesized clay via mild conditions. 
Montmorillonite and hectorite are the preferred layered materials for polymer 
nanocomposite systems (Alexandre and Dubois 2000, Carrado 2003, Chang et al. 2003, 
Gopakumar et al. 2002, Loo and Gleason 2004, Maiti et al. 2002, Matayabas and Turner 
2000, Nielsen 1967, Pinnavaia and Beall 2000, Strawhecker and Manias 2000). 
Another layered silicate, magadiite, is a member of a class of materials known as 
layered hydrous sodium (or alkali) polysilicates that also includes kanemite, makatite, 
kenyaite and octosilicate. Their structure is made up of negatively charged tetrahedral 
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silicate layers balanced by sodium cations. Magadiite has an even higher cation exchange 
capacity and aspect ratio compared to the smectites, and is easily synthesized under semi-
hydrothermal conditions (Feng and Balkus 2003, Kooli et al. 2006, Kwon et al. 1995, 
Kwon and Park 2004, Peng et al. 2005, Schwieger and Lagaly 2004, Wang et al. 2006, 
Zhang et al. 2003). Research has shown that the incorporation of exfoliated magadiite 
layers into epoxy nanocomposites has increased the tensile strength of the epoxy matrix, 
while still maintaining transparent optical properties (Wang et al. 1996, Wang and 
Pinnavaia 1998). To date, research of magadiite nanocomposites for improved gas barrier 
properties is limited. 
Theoretically, based on the gas barrier models presented in the following section, 
these layered silicates alone should improve the gas barrier of nanocomposites. However, 
unfavorable interactions between the hydrophilic silicates and the hydrophobic polymer 
may have a negative impact on other physical and mechanical properties. Therefore, the 
silicates are typically modified by covalently attaching organic functionalities to the 
surface hydroxyl groups, or by ion-exchanging with alkylammonium cations to expand 
the layers, and subsequently modify the interlayer surfaces (Peng et al. 2005, Zhang et al. 
2003, Fujita et al. 2003, Isoda and Kuroda 2000, Ogawa et al. 1998, Okutomo et al. 
1999, Wang et al. 2004). 
1.4. NANOCOMPOSITE THEORY 
There are three scenarios that can occur when a layered oxide is mixed with a 
polymer (Figure 1.1). First, the oxide can remain ordered and unexfoliated, forming a 
phase-separated composite. These conventional composites might have improved 
rigidity, but might sacrifice other properties such as elongation and toughness (LeBaron 
et al. 1999). Insertion of a polymer matrix into the layered silicate structure results in an 
intercalated nanocomposite, where the silicate layers remain ordered, but interfacial 
surface area between the silicate and polymer is greatly increased. This improves 
chemical, structural, and thermal stabilities compared to the polymer alone (Komori and 
Kuroda 2000). Finally, the best-case scenario would be complete exfoliation of the 
silicate layers well dispersed into the polymer. In this case, the clay-polymer interactions 
are maximized, and thus the chemical, physical, and mechanical properties are greatly 
enhanced. However, complete exfoliation is often a difficult task. Variables such as 
choice of matrix, process of incorporating the layered additive, choice of additive, 
treatment of additive (organic modification), and use of dispersing aids must be carefully 
considered (Matayabas and Turner 2000). Since exfoliation has been determined to have 
a profound effect on the performance of nanocomposites, a high aspect ratio of the 
separated layers would further improve the performance. Therefore, nanocomposites 
containing well-exfoliated silicate layers with the highest aspect ratio, to maximize the 
clay-polymer interactions, achieve the best results. 
Aspect ratio (a) is defined as the ratio of the lateral dimensions to the thickness of an 
exfoliated silicate platelet. Since the platelets are often irregular, the aspect ratio becomes 
a = ̂ r (!) 
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where A is the area of the platelet face, and Z is the thickness of the platelet (Auddy 
2007, Kloprogge et al 1999, Liu 2005, Ploehn and Liu 2006). It has been found that 
aspect ratio is crucial for improving certain properties, such as gas barrier (Alexandre and 
Dubois 2000, Jang and Lee 2004, Tsai 2000, Matayabas and Turner 2000). Nielsen 
developed the "tortuous path" theory to explain how aspect ratio effects the permeability 
of gases through a polymer (Alberti et al, 2007). An approximation of the permeability 
ratio can be represented as 
P (/> 
J__n_ _ rj_ ,~ 
P T 
± m 
where Pn is the permeability of the nanocomposite and Pm is the permeability of the 
unfilled polymer matrix, (|>p is the volume fraction of the polymer, and x is the tortuosity 
factor. The tortuosity factor is defined as the distance a gas molecule must travel through 
a polymer film divided by the thickness of the film. This factor is dependent on the aspect 
ratio in the following relationship: 
T = \ + CC0f (3) 
where <|)f is the volume fraction of filler additives and therefore equation 2 becomes 
I n _ rp 
Pm
 1 + °*f 
(4) 
for ideal nanocomposite systems. This model is represented schematically in Figure 1.2, 
where exfoliated platelets provide a more "tortuous path" for the gas to diffuse through 
the polymer. A barrier improvement factor (BIF) can be estimated from the 
permeabilities, where 
P 
BIF = ^^ (5) 
P 
and the BIF is used to quantify the barrier improvement of nanocomposites (Liu 2005, 
Matayabas and Turner 2000, Nielsen 1967). More advanced models were also developed 
to account for overlapping in "semi-dilute" nanocomposites systems (Matayabas and 
Turner 2000, Nielsen 1967). Based on calculated aspect ratios of synthesized silicates, 
the barrier improvement of a nanocomposite can be predicted from this theoretical model 
and compared to experimental BIF values determined by various methods. More 
advanced models were also developed to account for overlapping in "semi-dilute" 
nanocomposites systems (Cussler etal, 1998). 
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1.5. SUMMARY 
Polymer nanocomposites are an exciting and active research area that promises new 
materials with enhanced properties. These polymer nanocomposites consist of nano-
sized additives that are uniformly dispersed in a polymer host matrix, to generate 
substantial enhancements in physical properties relative to those of the pristine polymers. 
Research in nanocomposites has shifted towards layered oxides as the preferred additive, 
as their layered structure allows for exfoliation, or separation of layers, which increases 
the aspect ratio, and subsequently property enhancements. 
Layered Oxide Polymer 
Exfoliated 
Phase separated Intercalated 
Figure 1.1. Schematic illustrations of three possible scenarios for dispersion of layered oxides in a polymer 
matrix. 
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Figure 1.2. Illustration of the "tortuous path" model. Oxide platelets increase the path length of the gas, 
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Figure 1.3. Reaction scheme for the PET polymerization process. 
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